Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders

Critical Care

Volumn 16, Issue 4, 2012, Pages

  Hurley, James C ^a,b   Guidet, Bertrand ^c,d,e   Offenstadt, Georges ^c,d,e   Maury, Eric ^c,d,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BALLARAT HEALTH SERVICES   (Australia)

^c HÔPITAL SAINT ANTOINE   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; ENDOTOXEMIA; ESCHERICHIA COLI INFECTION; GRAM NEGATIVE INFECTION; HUMAN; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS; SURVIVAL; BACTEREMIA; EPIDEMIOLOGY; GRAM-NEGATIVE BACTERIAL INFECTIONS; LIMULUS LYSATE TEST; RISK; RISK FACTOR;

BACTEREMIA; CONFOUNDING FACTORS (EPIDEMIOLOGY); ENDOTOXEMIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LIMULUS TEST; ODDS RATIO; PROGNOSIS; RISK FACTORS;

EID: 84864772537     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11462     Document Type: Article

References (76)

1. Ahmed T, Azam MA, Armed N, Jamil KM, Hassan F, Ogura N, Tamura H, Yokochi T. Detection of endotoxin in sera from children hospitalized for treatment of diarrhea in Bangladesh. J Endotoxin Res 2004, 10:223-228.
2. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 1992, 20:1090-1096. 10.1097/00003246-199208000-00004, 1643887.
3. Cooperstock M, Riegle L. Plasma limulus gelation assay in infants and children: correlation with gram negative bacterial infection and evidence for "intestinal endotoxemia". Prog Clin Biol Res 1985, 189:329-345.
4. Klein K, Fuchs GJ, Kulapongs P, Mertz G, Suskind RM, Olson RE. Endotoxemia in protein-energy malnutrition. J Pediatr Gastroenterol Nutr 1988, 7:225-228. 10.1097/00005176-198803000-00012, 3127570.
5. Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 1988, 157:565-568. 10.1093/infdis/157.3.565, 3343526.
6. Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976, 63:774-778. 10.1002/bjs.1800631011, 791436.
7. Berger D, Boelke E, Stanescu A, Buttenschoen K, Vasilescu C, Seidelmann M, Beger HG. Endotoxemia and mediator release during colonoscopy. Endoscopy 1995, 27:671-675. 10.1055/s-2007-1005785, 8903980.
8. Foulis AK, Murray WR, Galloway D, McCartney AC, Lang E, Veitch J, Whaley K. Endotoxaemia and complement activation in acute pancreatitis in man. Gut 1982, 23:656-661. 10.1136/gut.23.8.656, 1419138, 7095560.
9. Lau JY, Chung SC, Leung JW, Ling TK, Yung MY, Li AK. Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg 1996, 83:181-184. 10.1002/bjs.1800830210, 8689158.
10. Lumsden AB, Henderson JM, Alspaugh J. Endotoxemia during percutaneous manipulation of the obstructed biliary tree. Am J Surg 1989, 158:21-24. 10.1016/0002-9610(89)90308-5, 2742045.
11. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989, 159:195-204. 10.1093/infdis/159.2.195, 2492587.
12. Brandtzaeg P, Hogasen K, Kierulf P, Mollnes TE. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternate pathway activation. J Infect Dis 1996, 173:647-655. 10.1093/infdis/173.3.647, 8627028.
13. Butler T, Levin J, Cu DQ, Walker RI. Bubonic plague: detection of endotoxemia with the limulus test. Ann Intern Med 1973, 79:642-646.
14. Butler T, Levin J, Linh NN, Chau DM, Adickman M, Arnold K. Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis 1976, 133:493-499. 10.1093/infdis/133.5.493, 1262715.
15. Magliulo E, Scevola D, Fumarola D, Vaccaro R, Bertotto A, Burberi S. Clinical experience in detecting endotoxemia with the limulus test in typhoid fever and other Salmonella infections. Infection 1976, 4:21-24. 10.1007/BF01638343, 977132.
16. Adinolfi LE, Utili R, Gaeta GB, Perna P, Ruggiero G. Presence of endotoxemia and its relationship to liver dysfunction in patients with typhoid fever. Infection 1987, 15:359-362. 10.1007/BF01647740, 3692608.
17. Suyasa IG, Reka IG, Inada K, Suda H, Kojima M, Mushiaki K, Okamoto S, Yoshida M. Plasma endotoxin in typhoid fever. Kobe J Med Sci 1995, 41:175-186.
18. Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, Hutton P, McMaster P, Buckels JA, Elliott TS. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 1994, 22:40-49.
19. Engervall P, Granstrom M, Andersson B, Kalin M, Bjorkholm M. Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern. Infection 1997, 25:2-7. 10.1007/BF02113498, 9039529.
20. Hynninen M, Valtonen M, Vaara M, Markkanen H, Kuusela P, Saxen H, Takkunen O. Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Micro Infect Dis 1995, 14:1039-1045.
21. Yoshida M, Obayashi T, Tamura H, Tanaka S, Kawai T, Sakamoto S, Miura Y. Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies. Eur J Cancer 1994, 30A:145-147.
22. Byl B, Clevenbergh P, Kentos A, Jacobs F, Marchant A, Vincent JL, Thys JP. Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. Eur J Clin Microbiol Infect Dis 2001, 20:804-807. 10.1007/s100960100609, 11783697.
23. Giamarellos-Bourboulis EJ, Perdios J, Lelekis M, Eoconomou E, Tsouroulas P, Giamarellou H. Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-a (TNF-a) blood levels in patients suffering from acute pyelonephritis: a preliminary report. Int J Antimicrob Agents 1999, 11:115-119. 10.1016/S0924-8579(98)00106-X, 10221414.
24. Levin J, Poore TE, Young NS, Margolis S, Zauber NP, Townes AS, Bell WR. Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids and complement. Ann Intern Med 1972, 76:1-7.
25. Stumacher RJ, Kovnat MJ, McCabe WR. Limitations of the usefulness of the limulus assay for endotoxin. N Engl J Med 1973, 288:1261-1264. 10.1056/NEJM197306142882402, 4574106.
26. van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PHP, Westendorp RGJ, van Dissel JT. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000, 31:1343-1348. 10.1086/317480, 11096000.
27. Bates DW, Parsonnet J, Ketchum PA, Novitsky TJ, Sands K, Hibberd PL, Graman PS, Lanken PN. Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. Clin Infect Dis 1998, 27:582-591. 10.1086/514713, 9770160.
28. Billard J-L, Berthier-Berrada S, Page Y, Géry P, Vermesch R, Page D, Ros A, Bertrand M, Bertrand JC. Endotoxemia in human septic shock: relation to gastric intra-mucosal pH. Crit Care Med 1994, 22:A113.
29. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parilllo JE. Endotoxemia in human septic shock. Chest 1991, 99:169-175. 10.1378/chest.99.1.169, 1984950.
30. Dofferhoff AS, Bom VJ, de Vries-Hospers HG, van Ingen J, vd Meer J, Hazenberg BP, Mulder PO, Weits J. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992, 20:185-192. 10.1097/00003246-199202000-00007, 1371097.
31. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC. Natural cytokine antagonists and endogenous anti-endotoxin core antibodies in sepsis syndrome. JAMA 1995, 274:172-177. 10.1001/jama.1995.03530020090038, 7596007.
32. Guidet B, Barakett V, Vassal T, Petit JC, Offenstadt G. Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994, 106:1194-1201. 10.1378/chest.106.4.1194, 7924495.
33. Strutz F, Heller G, Krasemann K, Krone B, Muller GA. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med 1999, 25:435-444. 10.1007/s001340050877, 10401935.
34. Wortel CH, von der Mohlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, ten Cate JW. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in Gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis 1992, 166:1367-1374. 10.1093/infdis/166.6.1367, 1431255.
35. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999, 180:1584-1589. 10.1086/315093, 10515819.
36. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-778.
37. Kollef MH, Eisenberg PR. A rapid quantitative assay to detect circulating endotoxin can predict the development of multiorgan dysfunction. Chest 1997, 112:173-180. 10.1378/chest.112.1.173, 9228373.
38. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004, 190:527-534. 10.1086/422254, 15243928.
39. Venet C, Zeni F, Viallon A, Ross A, Pain P, Gery P, Page D, Vermesch R, Bertrand M, Rancon F, Bertrand JC. Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med 2000, 26:538-544. 10.1007/s001340051201, 10923727.
40. van Deventer SJH, Buller HR, ten Cate JW, Sturk A, Pauw W. Endotoxemia: an early predictor of septicemia in febrile patients. Lancet 1988, 1:605-608.
41. Elin RJ, Robinson RA, Levine AS, Wolff SM. Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med 1975, 293:521-524. 10.1056/NEJM197509112931102, 1152876.
42. Hurley JC. Does gram negative bacteremia occur without endotoxemia? A meta-analysis using hierarchical summary ROC curves. Eur J Clin Microbiol Infect Dis 2010, 29:207-215. 10.1007/s10096-009-0841-2, 20084488.
43. Hurley JC. The detection of endotoxemia with Gram negative bacteremia is bacterial species dependent: A meta-analysis of clinical studies. J Clin Microbiol 2009, 47:3826-3831. 10.1128/JCM.01189-09, 2786621, 19794055.
44. Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Micro Rev 1995, 8:268-292. 172859, 7621402.
45. Munford RS. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?. Infect Immun 2008, 76:454-465. 10.1128/IAI.00939-07, 2223455, 18086818.
46. Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X, Roghmann MC. Risk of mortality with blood stream infection is higher in the less severely ill at admission. Am J Respir Crit Care Med 2005, 171:616-620.
47. McCabe WR, Jackson GG. Gram negative bacteremia. II Clinical laboratory and therapeutic observations. Arch Intern Med 1962, 110:856-864.
48. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gertenberger EP, Fitz Y, Danner RL, Natanson C. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002, 166:1197-1205. 10.1164/rccm.200204-302OC, 12403688.
49. Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?. Crit Care Med 2009, 37:S30-S37. 10.1097/CCM.0b013e3181922bd3, 19104223.
50. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007, 81:137-143.
51. Michie HR. The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother 1998, 41(suppl 1):47-49. 10.1093/jac/41.suppl_1.47, 9630374.
52. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998, 9:1-11.
53. Hurley JC. Endotoxemia and gram-negative bacteremias predictors of outcome in sepsis: a call for data. J Endotox Res 2001, 7:467.
54. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altmamn DG, Sterne JAC. Metan: fixed and random effects-meta-analysis. Stata J 2008, 8:3-28.
55. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
56. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987, 107:224-233.
57. Hurley JC. Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves. J Endotoxin Res 2003, 9:271-279.
58. Schedel I, Dreikhausen U, Nentwig B, Höckenschnieder M, Rauthmann D, Balikcioglu S, Coldewey R, Deicher H. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 1991, 19:1104-1113. 10.1097/00003246-199109000-00003, 1884609.
59. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991, 13:34-46.
60. Cohen J, Cristofaro P, Carlet J, Opal S. New method of classifying infections in critically ill patients. Crit Care Med 2001, 32:1510-1526.
61. Miller PJ, Wenzel RP. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 1987, 156:471-477. 10.1093/infdis/156.3.471, 3611832.
62. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005, 49:760-766. 10.1128/AAC.49.2.760-766.2005, 547233, 15673761.
63. Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005, 49:1306-1311. 10.1128/AAC.49.4.1306-1311.2005, 1068618, 15793102.
64. Dehus O, Hartung T, Hermann C. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res 2006, 12:171-180. 10.1179/096805106X102156, 16719988.
65. Devleeschouwer MJ, Cornil MF, Dony J. Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol 1985, 50:1509-1511. 238789, 3911908.
66. Danner RL, Natanson C, Elin RJ, Hosseini JM, Banks S, MacVittie TJ, Parrillo JE. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 1990, 98:1480-1487. 10.1378/chest.98.6.1480, 2245691.
67. Fine J, Frank ED, Ravin HA, Rutenberg SH, Schweinburg FB. The bacterial factor in traumatic shock. N Engl J Med 1959, 260:214-220. 10.1056/NEJM195901292600505, 13622952.
68. Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, Marshall JC. Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock 2007, 28:524-529.
69. Sharp SJ, Thompson SG. Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med 2000, 19:3251-3274. 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2, 11113958.
70. Song F. Exploring heterogeneity in meta-analysis: is the L'Abbé plotuUseful?. J Clin Epidemiol 1999, 58:717-723.
71. Egger M, Davey Smith G. Risks and benefits of treating mild hypertension: a misleading meta-analysis?. J Hypertension 1995, 13:813-815.
72. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005, 34:215-220.
73. Maury E, Blanchard HS, Chauvin P, Guglielminotti J, Alzieu M, Guidet B, Offenstadt G. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock. J Crit Care 2003, 18:115-120. 10.1053/jcrc.2003.50004, 12800122.
74. Warren HS, Danner RL, Munford RS. Anti-endotoxin monoclonal antibodies. N Engl J Med 1992, 326:1153-1157. 10.1056/NEJM199204233261711, 1552919.
75. Opal S, Gluck T. Endotoxin as a drug target. Crit Care Med 2003, 31:S57-S64. 10.1097/00003246-200301001-00009, 12544978.
76. Hurley JC. Reappraisal of the role of endotoxin in the sepsis syndrome. Lancet 1993, 341:1133-1135. 10.1016/0140-6736(93)93139-R, 8097815.